Browse by People

Collapse authors list.
Godman, Brian, McCabe, Holly, Leong, Trudy D, Mueller, Debjani, Martin, Antony P ORCID: 0000-0003-4383-6038, Hoxha, Iris, Mwita, Julius C, Rwegerera, Godfrey Mutashambara, Massele, Amos, Costa, Juliana de Oliveira et al (show 45 more authors) , do Nascimento, Renata Cristina Rezende Macedo, de Lemos, Livia Lovato Pires, Tachkov, Konstantin, Milushewa, Petya, Patrick, Okwen, Niba, Loveline Lum, Laius, Ott, Sefah, Israel, Abdulsalim, Suhaj, Soleymani, Fatemeh, Guantai, Anastasia N, Achieng, Loice, Oluka, Margaret, Jakupi, Arianit, Logviss, Konstantins, Hassali, Mohamed Azmi, Kibuule, Dan, Kalemeera, Francis, Mubita, Mwangana, Fadare, Joseph, Ogunleye, Olayinka O, Saleem, Zikria, Hussain, Shazhad, Bochenek, Tomasz, Mardare, Ileana, Alrasheedy, Alian A, Furst, Jurij, Tomek, Dominik, Markovic-Pekovic, Vanda, Rampamba, Enos M, Alfadl, Abubakr, Amu, Adefolarin A, Matsebula, Zinhle, Phuong, Thuy Nguyen Thi, Thanh, Binh Nguyen, Kalungia, Aubrey Chichonyi, Zaranyika, Trust, Masuka, Nyasha, Olaru, Ioana D, Wale, Janney, Hill, Ruaraidh ORCID: 0000-0002-2801-0505, Kurdi, Amanj, Timoney, Angela, Campbell, Stephen and Meyer, Johanna C (2020) Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 20 (1). pp. 1-26.

Collapse authors list.
Godman, Brian ORCID: 0000-0001-6539-6972, Grobler, Christoffel, Van-De-Lisle, Marianne, Wale, Janney, Barbosa, Wallace Breno, Massele, Amos, Opondo, Philip, Petrova, Guenka, Tachkov, Konstantin, Sefah, Israel et al (show 16 more authors) , Abdulsalim, Suhaj, Alrasheedy, Alian A, Unnikrishnan, Mazhuvancherry Kesavan, Garuoliene, Kristina, Bamitale, Kayode, Kibuule, Dan, Kalemeerar, Francis, Fadare, Joseph, Khan, Tanveer Ahmed, Hussain, Shahzad, Bochenek, Tomasz, Kalungia, Aubrey Chichonyi, Mwanza, James, Martin, Antony P ORCID: 0000-0003-4383-6038, Hill, Ruaraidh ORCID: 0000-0002-2801-0505 and Barbui, Corrado (2019) Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. EXPERT OPINION ON PHARMACOTHERAPY, 20 (18). pp. 2237-2255.